Chief Executive Officer

  • Has more than 25 years of industry experience including leadership positions at AstraZeneca, serving most recently as President of its US business, CEO North America, and Regional Vice President of the Americas
  • Served as board chairman of the National Pharmaceutical Council
  • Received his BA in Biology from Princeton University and an MBA from University of North Carolina at Chapel Hill



D.O., M.B.A. Chief Medical Officer

  • Has over 25 years of healthcare experience, the last 20 years in leadership positions in the pharmaceutical industry
  • Served as the Senior Vice-President of Clinical Development and Medical Affairs at Egalet, Vice-President of Global Medical Affairs for the CNS Business Unit and Vice-President of Global Medical Strategies at Shire, and Vice-President of Global Clinical Development at Cephalon
  • Practiced as a Neurologist with Indiana Neurology Associates, where she started an epilepsy monitoring unit and was medical director for a pain clinic


Chief Commercial Officer and Head of Business Development

  • Has more than 35 years of industry experience including commercial and business development leadership roles at AstraZeneca, Wyeth and Berlex Laboratories
  • Launched more than 20 new medicines, several which became some of the most successful brands in the pharmaceutical industry
  • Has experience in several categories including diabetes, cardiovascular, infectious disease, psychiatry, pain, neurology, respiratory, GI and arthritis
  • Received his BA in Biology from the University of Texas and an MBA from Amber University

Mark Uhle

Chief Financial Officer

  • Has over 25 years of industry experience including leadership positions in finance and accounting at AstraZeneca, most recently as Vice President of Internal Audit Services
  • Experienced in leading financial functions, holding multiple CFO roles within AstraZeneca including CFO Americas, CFO North America, and CFO IPR Pharmaceuticals (one of AstraZeneca’s largest operations sites)
  • Mark received his BA in economics from Northwestern University and an MBA from the Wharton School of the University of Pennsylvania


General Counsel

  • Has over 25 years of industry experience ranging across legal and compliance, technical operations, commercial, and government affairs
  • Served in leadership roles and increasingly senior legal and compliance roles, including as General Counsel and Compliance Officer for Churchill Pharmaceuticals and legal leadership positions within Incyte Corporation and Celgene Corporation
  • Served in leadership positions with PhRMA, BIO and industry compliance coalitions
  • Earned a Bachelor of Mechanical Engineering from Villanova University and JD from Suffolk University Law School